Sarcoma  >>  Neulasta (pegfilgrastim)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neulasta (pegfilgrastim) / Roche
NCT00283621: Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide

Completed
N/A
51
US
Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), Adriamycin, Doxorubicin Hydrocholoride, Adriamycin PFS, Adriamycin RDF, Ifosfamide, Ifex
M.D. Anderson Cancer Center, Amgen
Sarcoma
04/06
04/06
NCT00346125: PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma

Completed
N/A
70
US
pegfilgrastim, Neulasta(R), doxorubicin hydrochloride, Doxorubicin, Adriamycin, ifosfamide, Mitoxana, Ifex, pegylated liposomal doxorubicin hydrochloride, doxorubicin-hydrochloride-liposome, conventional surgery, fludeoxyglucose F 18, FDG
Masonic Cancer Center, University of Minnesota
Sarcoma
07/13
07/22

Download Options